Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Feb 2019 07:00

RNS Number : 4282P
Premier Veterinary Group PLC
08 February 2019
 

 

PREMIER VETERINARY GROUP PLC

 

NOTIFICATION OF TRANSACTIONS OF PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR)

 

London, UK, 08 February 2019 (LSE: PVG): Premier Veterinary Group plc ("the Company") announces that it has received notification that on 07 February 2019, Rajan Uppal, a Director of the Company:

 

Disposed of 195,000 ("Ordinary Shares") in the Company held in his own name to a nominee account held by Investec Bank Plc.

 

There is no change to Mr Uppal's beneficial interest as a result of this transaction, this being 5,421,138 Ordinary Shares in the Company, representing 35.324% of the total voting rights of the Company.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated 

 

a)

Name 

 

Rajan Uppal

 

2

Reason for the notification

 

a)

Position/status

 

Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Premier Veterinary Group plc

b)

LEI

 

 2138009B5L8VQUZ9A719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

Description of the financial instrument, type of instrument

Identification code 

 

Ordinary Shares of £0.10 each

 

 

ISIN: GB00BSZLMS59

b)

Nature of the transaction

Transfer of 195,000 ordinary shares from Mr Uppal personally to SIPP account held at Investec Bank plc;

there was no change in beneficial ownership

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.41

195,000 shares

 

d)

Aggregated information

 

- Aggregated volume

- Price 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total 

N/A

N/A

N/A

e)

Date of the transaction

 

07 February 2019 

f)

Place of the transaction

 

Outside of trading venue

 

For further information, please contact:

 

Premier Veterinary Group plc

Tel:  +44(0)117 970 4127

Dominic Tonner, Chief Executive Officer

Andrew Paull, Chief Financial Officer

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFERFAIDIIA
Date   Source Headline
14th Jun 201011:45 amRNSForm 8.5 (EPT/RI)
14th Jun 20109:16 amRNSForm 8.5 (EPT/NON-RI)
11th Jun 20102:06 pmRNSForm 8.3 - Ark Therapeutics Group PLC
11th Jun 201012:46 pmRNSForm 8.3 - Ark Therapeutics Plc
11th Jun 201010:16 amRNSForm 8.5 (EPT/RI)
11th Jun 20109:52 amRNSForm 8.5 (EPT/NON-RI)
10th Jun 201010:17 amRNSForm 8.5 (EPT/NON-RI)
10th Jun 201010:13 amRNSForm 8.5 (EPT/RI)
9th Jun 201011:38 amRNSForm 8.5 (EPT/RI)
9th Jun 201010:08 amRNSForm 8.5 (EPT/NON-RI)
8th Jun 20104:40 pmRNSSecond Price Monitoring Extn
8th Jun 20104:35 pmRNSPrice Monitoring Extension
8th Jun 201012:36 pmRNSForm 8.3 - Ark Therapeutics
8th Jun 201011:15 amRNSForm 8.5 (EPT/NON-RI)
8th Jun 201011:11 amRNSForm 8.5 (EPT/RI)
7th Jun 20102:53 pmRNSForm 8.3 - Ark Therapeutics Group PLC
7th Jun 201011:55 amRNSForm 8.3 - [Ark Therapeutics Group plc]
7th Jun 201011:04 amRNSForm 8.5 (EPT/RI)-Amendment
7th Jun 201011:04 amRNSForm 8.5 (EPT/RI)
7th Jun 20109:41 amRNSForm 8.5 (EPT/NON-RI)
4th Jun 201012:43 pmRNSForm 8.3 - ARK THERAPEUTICS
4th Jun 201011:43 amRNSForm 8.5 (EPT/RI)
4th Jun 201010:25 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 20102:53 pmRNSForm 8.3 - Ark Therapeutics Group PLC
3rd Jun 201011:37 amRNSForm 8.5 (EPT/RI)
3rd Jun 201011:25 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 201010:28 amRNSBlocklisting Interim Review
2nd Jun 20103:07 pmRNSForm 8.3 - Ark Therapeutics Group PLC
2nd Jun 201011:38 amRNSForm 8.5 (EPT/RI)
2nd Jun 20109:22 amRNSForm 8.5 (EPT/NON-RI)
1st Jun 20102:47 pmRNSForm 8.3 - Ark Therapeutics Group PLC
1st Jun 20102:45 pmRNSForm 8.3 - Ark Therapeutics
1st Jun 201010:08 amRNSForm 8.5 (EPT/NON-RI)
28th May 201011:08 amRNSForm 8.5 (EPT/NON-RI)
27th May 20103:17 pmRNSForm 8.3 - Ark Therapeutics Group PLC
27th May 201010:41 amRNSForm 8.5 (EPT/RI)
27th May 20109:04 amRNSForm 8.5 (EPT/NON-RI)
26th May 201011:45 amRNSForm 8.5 (EPT/NON-RI)
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
25th May 201010:44 amRNSForm 8.5 (EPT/NON-RI)
24th May 20109:10 amRNSForm 8.5 (EPT/NON-RI)
24th May 20107:00 amRNSAppointment of CFO and Company Secretary
21st May 20103:32 pmRNSForm 8.5 (EPT/RI)
21st May 20109:55 amRNSForm 8.5 (EPT/NON-RI)
20th May 20109:50 amRNSForm 8.5 (EPT/NON-RI)
19th May 201010:48 amRNSForm 8.5 (EPT/NON-RI)
18th May 201011:05 amRNSForm 8.5 (EPT/NON-RI)
18th May 201010:11 amRNSForm 8.5 (EPT/RI)
18th May 20107:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.